Less Ads, More Data, More Tools Register for FREE

Pin to quick picksXaar Regulatory News (XAR)

Share Price Information for Xaar (XAR)

Share Price is delayed by 15 minutes
Get Live Data
145.00    3.00 (2.11%)
Bid:
140.50
Ask:
144.50
Spread: 4.00 (2.847%)
Market Cap: £113.79m
XAR Live PriceLast checked at - London Stock Exchange

Intraday Xaar Share Chart

Board Changes

11 Dec 2015 07:00

RNS Number : 7363I
Xaar PLC
11 December 2015
 



11 December 2015

 

Xaar plc

 

Board changes

 

Xaar plc, "Xaar", "the Company", the world leader in industrial inkjet technology, announces two Board changes.

 

Firstly, Xaar is pleased to announce the appointment of Chris Morgan as Non-Executive Director, who will join the Board of Directors at Xaar from 4 January 2016. Chris will also serve as a member of the Audit, Nomination and Remuneration Committees.

 

Chris brings with him a wealth of expertise in managing complex international technology businesses, having spent 25 years at HP, Inc. Chris's HP career encompassed more than 15 years of diverse senior executive roles including WW Sales and Marketing leadership for HP's entire printing business and Senior Vice President of Graphic Solutions where he had end-to-end global general management responsibility for HP's multibillion dollar portfolio of digital printing and packaging press, signage and display, large format design, 3D, and specialty printing solutions and services.

 

Chris has a strong background in global marketing and general management roles, with 11 years living and working in Asia for HP. He has led strategic investments in key growth markets such as China and India and has established channel networks, and customer service and supply chain capabilities in growth markets. Chris has also been involved in a number of mergers and acquisitions at both the strategic and operational levels and was a Board member for an HP-Softbank PC-related joint venture in Japan, and recently served as Chief Marketing Officer for Stratasys, Ltd, until June of 2015, where he was responsible for marketing 3D printing and additive manufacturing solutions globally.

 

Phil Lawler, Xaar's Chairman, welcomes Chris saying, "We are delighted that Chris is joining Xaar's Board. He brings a wealth of experience with him in both global businesses and leadership roles. We look forward to his help in guiding the Company at this important period in Xaar's 25 year history." Doug Edwards, Xaar's CEO, added, "I am pleased to welcome Chris to Xaar. His extensive international experience and market knowledge will aid Xaar's growth in new and emerging applications for digital inkjet printing."

 

The appointment of Chris to Xaar's Board will prove a very positive start to 2016 for the Company. Chris Morgan said, "Xaar is well positioned to take advantage of a number of growth opportunities in the digital print market over the next few years and I am very excited to be joining Xaar at this important time."

 

No further information is required to be disclosed in relation to Chris Morgan pursuant to Listing Rule 9.6.13 R.

 

Xaar also announces the resignation of Richard Barham, Chief Customer Officer, from the Board with immediate effect. The Board does not anticipate replacing the role of Chief Customer Officer with another Board Appointment. We will be realigning the business to support our long term commercial vision and support our partnership strategy.

 

Doug Edwards, Chief Executive Officer, commented: "The Board has accepted Richards' resignation as a Board Director. The business would like to thank him for his service to the Company. We wish him every success for the future".

 

 

Contacts

 

Xaar plc

Alex Bevis, CFO

+44 (0) 1223-423663

www.xaar.com

Tulchan Communications

James Macey White

 

+44 (0) 20-7353-4200

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAUROARVBAUAUA
Date   Source Headline
3rd Feb 20254:15 pmRNSTotal Voting Rights
22nd Jan 202512:30 pmRNSBlock listing Interim Review
21st Jan 20253:00 pmRNSHolding(s) in Company
15th Jan 20257:00 amRNSTrading update & notification of full year results
15th Jan 20257:00 amRNSAppointment of Chief Financial Officer
11th Dec 202410:30 amRNS2024 Full Year Trading Update
4th Dec 202410:45 amRNSUpdate statement on 2024 AGM voting results
3rd Dec 202410:50 amRNSTotal Voting Rights
20th Nov 20247:00 amRNSBoard changes
1st Nov 202412:00 pmRNSTotal Voting Rights
1st Oct 202411:30 amRNSTotal Voting Rights
18th Sep 20247:00 amRNSInterim Results
2nd Sep 20241:45 pmRNSTotal Voting Rights
2nd Aug 20242:30 pmRNSHolding(s) in Company
1st Aug 202411:15 amRNSTotal Voting Rights
30th Jul 20247:00 amRNSNOTICE OF RESULTS AND UPDATE ON TRADING
3rd Jul 202411:45 amRNSBlock listing Interim Review
2nd Jul 20242:00 pmRNSTotal Voting Rights
28th Jun 202410:00 amRNSDirector Declaration
3rd Jun 20242:45 pmRNSTotal Voting Rights
30th May 202412:00 pmRNSBoard changes
29th May 20241:45 pmRNSResult of AGM
29th May 20249:30 amRNSHolding(s) in Company
21st May 20249:30 amRNSDirector/PDMR Shareholding
20th May 20244:30 pmRNSDirector/PDMR Shareholding
13th May 20249:42 amRNSHolding(s) in Company
1st May 20244:15 pmRNSTotal Voting Rights
30th Apr 20244:30 pmRNSDirector/PDMR Shareholding
22nd Apr 202410:51 amRNSAnnual Financial Report
2nd Apr 202412:00 pmRNSTotal Voting Rights
1st Mar 202410:15 amRNSTotal Voting Rights
26th Feb 20249:00 amRNSHolding(s) in Company
23rd Feb 202410:30 amRNSBoard Change
1st Feb 20241:32 pmRNSTotal Voting Rights
29th Jan 202412:04 pmRNSHolding(s) in Company
12th Jan 20243:15 pmRNSBlock listing Interim Review
12th Jan 20247:00 amRNSNotification of Results & Full year Guidance
8th Jan 202412:36 pmRNSTotal Voting Rights
12th Dec 20239:00 amRNSNotification of Transactions of Directors & PDMRs
11th Dec 20233:00 pmRNSNotification of Transactions of Directors & PDMRs
1st Dec 202311:00 amRNSTotal Voting Rights
1st Dec 202310:00 amRNSDirector Declaration
29th Nov 20237:00 amRNSTrading Update
17th Nov 20234:07 pmRNSHolding(s) in Company
9th Nov 20231:53 pmRNSDirector/PDMR Shareholding
3rd Nov 202310:52 amRNSHolding(s) in Company
1st Nov 20234:03 pmRNSTotal Voting Rights
30th Oct 20237:00 amRNSBoard Changes
2nd Oct 202311:45 amRNSTotal Voting Rights
21st Sep 20233:16 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.